West Pharmaceutical Services, Inc. company logo
West Pharmaceutical Services, Inc. logo

WST Cash From Financing

Annual CFF

-$622.60M$163.00M-35.47%

Summary

Current Value
As of today, WST annual cash from financing is -$622.60M, down -35.47% on
Historical Performance
WST annual cash from financing is down -270.37% over the past 3 years, and down -1591.85% over the past 5 years
All-Time High Comparison
WST annual cash from financing is currently -616.68% below its historical high of $120.50M set on
3-Year Low Comparison
WST annual cash from financing is at its 3-year low
Sector Comparison
WST annual cash from financing is higher than 4.76% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

WST Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$622.60M-35.5%-270.4%-1591.8%-2654.9%
Quarterly Cash From Financing-$11.50M+82.1%+84.7%-59.7%-173.8%
TTM Cash From Financing-$242.30M+67.4%+16.5%-213.1%-556.6%
Price$275.52-18.2%+14.4%-10.4%+1251.3%
Annual Cash From Operations$653.40M-15.8%+11.9%+77.9%+374.5%
Annual Cash From Investing-$378.70M-2.7%-49.6%-66.1%-210.7%
Annual Dividends Paid$59.10M+3.7%+15.7%+31.0%+194.0%
Annual Total Debt$305.30M-1.2%-6.2%-7.3%-19.6%
Shares Outstanding71.94M-0.5%-2.9%-2.8%

Cash From Financing Highs

WST Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$293.60MN/A-112.1%
5Y-$137.10MN/A-354.1%
All$120.50M-616.7%

Cash From Financing Lows

WST Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$622.60Mat low
5Y-$622.60Mat low
All-$622.60Mat low

Cash From Financing History

YearValueChange
-$622.60M-35.5%
-$459.60M-56.5%
-$293.60M-74.7%
-$168.10M-22.6%
-$137.10M-272.6%
-$36.80M+54.4%
YearValueChange
-$80.70M+26.0%
-$109.00M+4.3%
-$113.90M-174.5%
-$41.50M-34.7%
-$30.80M-

FAQ

  • What is the current annual cash from financing of WST?

    As of today, WST annual cash from financing is -$622.60M

  • What is 1-year change in WST annual cash from financing?

    WST annual cash from financing is down -35.47% year-over-year

  • What is 3-year change in WST annual cash from financing?

    WST annual cash from financing is down -270.37% over the past 3 years

  • How far is WST annual cash from financing from its all-time high?

    WST annual cash from financing is currently -616.68% below its historical high of $120.50M set on December 31, 2005

  • How does WST annual cash from financing rank versus sector peers?

    WST annual cash from financing is higher than 4.76% of companies in Healthcare sector

  • When is WST next annual earnings release?

    The next annual earnings release for WST is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. WST Official Website www.westpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577025000093/0000105770-25-000093-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577025000013/0000105770-25-000013-index.htm
  4. WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
  5. WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst